754 related articles for article (PubMed ID: 22902970)
1. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
Konsoula Z; Barile FA
J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
[TBL] [Abstract][Full Text] [Related]
2. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
Ganai SA; Banday S; Farooq Z; Altaf M
Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
4. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.
Gupta R; Ambasta RK; Kumar P
Life Sci; 2020 Feb; 243():117278. PubMed ID: 31926248
[TBL] [Abstract][Full Text] [Related]
7. Human neuronal cells: epigenetic aspects.
Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
[TBL] [Abstract][Full Text] [Related]
8. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.
Sharma S; Sarathlal KC; Taliyan R
CNS Neurol Disord Drug Targets; 2019; 18(1):11-18. PubMed ID: 30289079
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
11. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
12. Targeting the correct HDAC(s) to treat cognitive disorders.
Fischer A; Sananbenesi F; Mungenast A; Tsai LH
Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
[TBL] [Abstract][Full Text] [Related]
13. A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory.
Mahgoub M; Monteggia LM
Learn Mem; 2014 Oct; 21(10):564-8. PubMed ID: 25227251
[TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
Ganai SA; Ramadoss M; Mahadevan V
Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502
[TBL] [Abstract][Full Text] [Related]
15. The potential of HDAC inhibitors as cognitive enhancers.
Gräff J; Tsai LH
Annu Rev Pharmacol Toxicol; 2013; 53():311-30. PubMed ID: 23294310
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases in memory and cognition.
Penney J; Tsai LH
Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
[TBL] [Abstract][Full Text] [Related]
17. Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure.
Evans LW; Ferguson BS
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30126190
[TBL] [Abstract][Full Text] [Related]
18. A translational perspective on histone acetylation modulators in psychiatric disorders.
Ganguly S; Seth S
Psychopharmacology (Berl); 2018 Jul; 235(7):1867-1873. PubMed ID: 29915963
[TBL] [Abstract][Full Text] [Related]
19. [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
Gomazkov OA
Eksp Klin Farmakol; 2015; 78(11):35-44. PubMed ID: 27017704
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles of HDAC inhibition in neurodegenerative conditions.
Chuang DM; Leng Y; Marinova Z; Kim HJ; Chiu CT
Trends Neurosci; 2009 Nov; 32(11):591-601. PubMed ID: 19775759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
